Pharmacokinetics of remifentanil in conscious cats and cats anesthetized with isoflurane
Authors:
- Bruno H. PypendopBPBruno H. Pypendop
- Robert J. BrosnanRBRobert J. Brosnan
- Kristine T. SiaoKSKristine T. Siao
- Scott D. StanleySSScott D. Stanley
- 1 April 2008
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 69 (4) , 531-536
Abstract
Objective—To characterize the pharmacokinetics of remifentanil in conscious cats and cats anesthetized with isoflurane. Animals—6 cats. Procedures—Remifentanil (1 μg/kg/min for 5 minutes) was administered IV in conscious cats or cats anesthetized with 1.63% isoflurane in oxygen in a randomized crossover design. Blood samples were obtained immediately prior to remifentanil administration and every minute for 10 minutes, every 2 minutes for 10 minutes, and every 5 minutes for 10 minutes after the beginning of the infusion. Blood was immediately transferred to tubes containing citric acid, flash frozen in liquid nitrogen, and stored at −80°C until analysis. Blood remifentanil concentration was determined by use of liquid chromatography–mass spectrometry. Remifentanil concentration-time data were fitted to compartment models. Results—A 2-compartment model (with zero-order input because of study design) best described the disposition of remifentanil in awake and isoflurane-anesthetized cats. The apparent volume of distribution of the central compartment, the apparent volume of distribution at steady state, the clearance, and the terminal half-life (median [range]) were 1,596 (1,164 to 2,111) and 567 (278 to 641) mL/kg, 7,632 (2,284 to 76,039) and 1,651 (446 to 29,229) mL/kg, 766 (408 to 1,473) and 371 (197 to 472) mL/min/kg, and 17.4 (5.5 to 920.3) and 15.7 (3.8 to 410.3) minutes in conscious and anesthetized cats, respectively. Conclusions and Clinical Relevance—The disposition of remifentanil in cats was characterized by a high clearance. Isoflurane anesthesia significantly decreased the volume of the central compartment, likely by decreasing blood flow to vessel-rich organs.Keywords
This publication has 35 references indexed in Scilit:
- A Review of the Pharmacokinetics and Pharmacodynamics of RemifentanilAnesthesia & Analgesia, 1999
- An Overview of RemifentanilAnesthesia & Analgesia, 1999
- Pharmacokinetics Anesthesiologists, and Pharmacodynamics of Remifentanil in Persons with Renal Failure Compared with Healthy VolunteersAnesthesiology, 1997
- Pharmacokinetics and Pharmacodynamics of Remifentanil in Volunteer Subjects with Severe Liver DiseaseAnesthesiology, 1996
- Pharmacokinetics, Pharmacodynamics, and Rational Opioid SelectionAnesthesiology, 1991
- Idiosyncracies of Drug Metabolism in Cats: Effects on Pharmacotherapeutics in Feline PracticeVeterinary Clinics of North America: Small Animal Practice, 1984
- Factors influencing the cholinesterases of cerebrospinal fluid in the anaesthetized catNeuroscience, 1984
- Pseudocholinesterases of mammalian plasma: Physicochemical properties and organophosphate inhibition in eleven speciesToxicology and Applied Pharmacology, 1973
- Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine/DTNB procedureToxicology and Applied Pharmacology, 1970
- Hydrolysis of suxamethonium by different types of plasmaBritish Journal of Pharmacology, 1969